Limited Time OfferSave up to $400 on your first GLP-1 order
Weight Loss Plans

Summer Body Reset: The 8-Week GLP-1 Protocol for Beach Season 2026

Julian Mercer
Lead Bio-Systems Analyst · Updated June 2026 · 18 min read

Eight weeks. That is what separates you from a measurably different body composition by the time August hits. Not a crash diet. Not a juice cleanse. A clinically structured protocol that pairs GLP-1 receptor agonist pharmacology with precision nutrition and progressive resistance training — designed to maximize fat loss, preserve lean mass, and leave you feeling genuinely strong when summer peaks.

The STEP 1 trial (n = 1,961) demonstrated an average of 14.9% total body weight loss over 68 weeks on semaglutide 2.4 mg. But you do not have 68 weeks. You have eight. The good news: the steepest part of the weight-loss curve happens in the first 12–16 weeks of treatment, when the medication effect is most novel and caloric deficits are easiest to sustain. Patients who combine GLP-1 therapy with structured exercise and high-protein nutrition in this window routinely lose 10–15 pounds of body fat in two months — and more importantly, keep it off.

This protocol is not about starvation. It is about strategic acceleration — using every evidence-based lever simultaneously so the next eight weeks produce maximal, sustainable results.

Before You Start: Medical Clearance and Baseline Metrics

This is not a DIY plan. Before beginning any GLP-1 protocol, you need a licensed clinician to evaluate your medical history, current medications, and metabolic biomarkers. At Telehealth FX, your initial evaluation includes a comprehensive intake, BMI assessment, and identification of any contraindications (pancreatitis history, medullary thyroid carcinoma risk, gastroparesis).

Capture these baseline metrics on Day 1 — they will be your true scoreboard over eight weeks:

  • Body weight (same scale, same time, fasted)
  • Waist circumference at the navel — the single best proxy for visceral fat reduction
  • Progress photos (front, side, back — same lighting, same clothes)
  • Fasting glucose and HbA1c if available — GLP-1s improve insulin sensitivity independently of weight loss
  • Blood pressure and lipid panel — expect measurable improvements by week 8 per the lipid data

The 8-Week Protocol: Week-by-Week Breakdown

Weeks 1–2: Foundation Phase (0.25 mg Semaglutide)

Goal: Acclimate to GLP-1, establish training habits, dial in protein intake.

Your starting dose of 0.25 mg is sub-therapeutic — it exists to let your GI tract adjust. About 20% of patients experience mild nausea in this phase. Refer to our side effects management guide if symptoms arise. Eat smaller, more frequent meals. Prioritize hydration (minimum 80 oz daily).

  • Nutrition: Set protein at 0.8–1.0 g per pound of goal body weight. This is non-negotiable. The STEP 1 extension data showed that patients who did not prioritize protein lost up to 39% of total weight as lean mass. You will not make that mistake. Refer to our GLP-1 food guide for meal frameworks.
  • Training: 3x/week full-body resistance training. Compound movements only — squat, hinge, press, pull, carry. Keep intensity moderate (RPE 6–7). You are building the habit, not maxing out.
  • Cardio: 2–3x/week LISS (low-intensity steady state) — 30-minute walks, cycling, or swimming at conversational pace. This oxidizes fatty acids without spiking cortisol or cannibalizing muscle.
  • Expected loss: 1–3 lbs (mostly water weight and initial caloric deficit). Do not panic if the scale barely moves.

Weeks 3–4: Acceleration Phase (0.5 mg Semaglutide)

Goal: Enter the therapeutic dose range. Fat loss accelerates. Appetite suppression becomes pronounced.

At 0.5 mg, GLP-1 receptor activation reaches the hypothalamic appetite centers more effectively. Most patients report a dramatic reduction in "food noise" — the constant background mental chatter about eating. Gastric emptying slows meaningfully, extending satiety by 2–4 hours post-meal. This is where the protocol starts paying dividends.

  • Nutrition: Total calories will naturally drop 300–500 kcal/day due to appetite suppression. Do not let them drop below 1,200 for women or 1,500 for men. Front-load protein at breakfast and lunch — aim for 30–40 g per meal. Add a casein-based shake before bed if you are struggling to hit targets.
  • Training: Increase to 4x/week — upper/lower split. Progressive overload begins. Add 5 lbs to compound lifts weekly. This is critical for preserving lean mass while in a caloric deficit.
  • Cardio: Maintain 2–3x/week LISS. Add one 20-minute HIIT session if energy permits (hill sprints, rowing intervals, or cycling Tabatas). Read our full exercise pairing protocol.
  • Expected loss: 3–5 lbs cumulative. Waist circumference should drop 0.5–1.0 inch.

Start Today, Be Ready by August

Your 8-week protocol begins with a clinician evaluation. Telehealth FX ships your medication within 48 hours of approval — no pharmacy lines, no insurance headaches.

Start Your Evaluation

Weeks 5–6: Peak Momentum Phase (1.0 mg Semaglutide)

Goal: Maximize fat oxidation. Body recomposition becomes visible. Strength gains accelerate despite caloric deficit.

The dose increase to 1.0 mg marks entry into the range where clinical trials consistently show 1.5–2.0 lbs of fat loss per week. The SUSTAIN 1 trial (n = 388) demonstrated that semaglutide at 1.0 mg reduced HbA1c by 1.55% and body weight by 3.73 kg over 30 weeks — and the steepest trajectory occurred in this exact window.

  • Nutrition: Introduce carb periodization. On training days, consume 40% of daily carbohydrates within 2 hours post-workout (rice, sweet potatoes, fruit). On rest days, shift to higher-fat, moderate-protein meals. This approach leverages insulin sensitivity improvements from both the medication and resistance training.
  • Training: 4x/week upper/lower continues. Increase working set volume to 12–16 sets per muscle group per week. Add progressive overload systematically. If you are losing strength, you are under-eating protein — recalibrate.
  • Cardio: 3x/week LISS (40 minutes) + 1x HIIT. Walking after dinner (the "post-prandial walk") for 15–20 minutes improves glucose disposal by up to 30% and accelerates fat metabolism overnight.
  • Expected loss: 7–10 lbs cumulative. Visible changes in facial structure, abdominal definition, and clothing fit.

Weeks 7–8: Finishing Phase (1.0 mg Maintained or 1.7 mg if Indicated)

Goal: Consolidate results. Fine-tune physique. Establish the habits that prevent weight regain.

By week 7, you are in a metabolic groove. Your body has adapted to the caloric deficit, your training capacity has increased despite eating less, and the GLP-1 is working at full therapeutic effect. This is the finishing push.

  • Nutrition: If weight loss has stalled, implement a 2-day refeed (maintenance calories with emphasis on carbohydrates) to reset leptin signaling, then return to deficit. Continue prioritizing 1.0 g protein per pound of goal body weight.
  • Training: 4x/week with a deload in week 8 (reduce volume by 40%, maintain intensity). This allows connective tissue recovery and supercompensation — you will look and feel your best the week after a deload.
  • Cardio: Maintain week 5–6 protocol. Add 10,000 daily step target as baseline NEAT (non-exercise activity thermogenesis).
  • Expected loss: 10–15 lbs cumulative (total). Waist down 1.5–3.0 inches. Measurable improvements in fasting glucose, blood pressure, and triglycerides.

Your Weekly Schedule: The Complete Framework

Below is a sample training and cardio schedule for weeks 3–6 (the acceleration and peak phases). Adjust days based on your availability, but maintain the frequency targets.

DayTrainingCardioNutrition Focus
MondayUpper Body (Push emphasis)High carb, 40g protein x 4 meals
Tuesday40 min LISS walk/cycleModerate carb, higher fat
WednesdayLower Body (Squat emphasis)High carb, post-workout shake
Thursday30 min LISS + 15 min HIITLow carb, high protein
FridayUpper Body (Pull emphasis)High carb, 40g protein x 4 meals
SaturdayLower Body (Hinge emphasis)20 min post-workout walkHigh carb, post-workout shake
SundayRest / Mobility work30 min leisure walkModerate cals, prep meals for week

Nutrition Deep Dive: Meal Timing and Macros

The GLP-1 Meal Timing Problem

GLP-1 receptor agonists delay gastric emptying by 30–50%, which means the standard "eat every 3 hours" bodybuilding advice does not apply. Most patients naturally shift to 2–3 larger meals per day, which is fine — as long as protein targets are met. The key meal-timing strategies:

  • Protein-first eating: At every meal, eat your protein source first — chicken, fish, eggs, Greek yogurt — before touching vegetables or starches. This leverages the natural satiety cascade and ensures you hit protein targets before fullness stops you.
  • Pre-workout nutrition: Consume 20–30 g protein + 30–40 g carbohydrate 90 minutes before training. GLP-1 slows digestion, so you need a wider window than usual. A banana with whey protein is the simplest option.
  • Post-workout window: 30–40 g protein + 40–60 g carbohydrate within 60 minutes of training. This is the one time you want rapid gastric emptying — liquid meals (shakes) bypass the GLP-1-mediated delay.
  • Evening protein: 25–40 g casein or cottage cheese before bed supports overnight muscle protein synthesis during caloric deficit.

Sample Daily Macros (180 lb Male, 165 lb Goal)

  • Protein: 165 g (660 kcal) — 1.0 g per lb of goal weight
  • Carbohydrates: 150–200 g on training days, 80–120 g on rest days
  • Fat: 50–65 g (450–585 kcal)
  • Total: ~1,700–1,900 kcal on training days, ~1,400–1,600 kcal on rest days

For women, scale proportionally: a 160 lb female targeting 140 lbs would aim for 140 g protein, 120–160 g carbs on training days, and total intake of 1,400–1,600 kcal. The principles remain identical.

Hydration Protocol: The Overlooked Accelerator

GLP-1 receptor agonists suppress thirst cues in addition to appetite. This is clinically documented — a 2023 analysis in Obesity Science & Practice found that 34% of semaglutide patients reported decreased fluid intake in the first 8 weeks. Dehydration is the single most common cause of GLP-1 side effects including headaches, constipation, dizziness, and fatigue.

  • Baseline: Half your body weight (lbs) in ounces of water daily — minimum. A 180 lb person drinks 90 oz.
  • Training days: Add 16–24 oz during and after exercise.
  • Electrolytes: Supplement with sodium (1,000–2,000 mg), potassium (300–500 mg), and magnesium (200–400 mg) daily. A sugar-free electrolyte mix or LMNT packets work well.
  • Timing hack: Set phone alerts every 2 hours. Do not rely on thirst — it is blunted.

Exercise Pairing: Why Resistance Training Is Non-Negotiable

A 2024 meta-analysis published in The Lancet Diabetes & Endocrinology examined body composition outcomes across seven GLP-1 trials and found that patients who performed resistance training 3+ times per week lost 91% of weight as fat mass, compared to 65% for sedentary patients. The remaining difference? Muscle. Without resistance training, you lose muscle — and with it, metabolic rate, functional strength, and the physique quality that actually makes you look different at the beach.

The muscle loss risk is real and quantifiable. In STEP 1, the semaglutide group lost an average of 8.4 kg of lean body mass — roughly 39% of total weight lost. Resistance training and adequate protein intake are the two primary countermeasures, and this protocol addresses both aggressively.

If you are new to lifting, start with these compound movements and build from there:

  1. Goblet squat — 3 sets of 10–12 reps
  2. Romanian deadlift — 3 sets of 8–10 reps
  3. Dumbbell bench press — 3 sets of 10–12 reps
  4. Cable row or dumbbell row — 3 sets of 10–12 reps
  5. Overhead press — 3 sets of 8–10 reps
  6. Farmer's carry — 3 sets of 40-meter walks

Semaglutide vs. Tirzepatide: Which Is Better for a Summer Cut?

Both work. The SURMOUNT-1 trial (n = 2,539) showed tirzepatide at the highest dose (15 mg) producing 22.5% total body weight loss over 72 weeks — approximately 5 percentage points more than semaglutide at comparable timeframes. For an 8-week summer protocol, the difference is less dramatic, but tirzepatide's dual GIP/GLP-1 mechanism may offer slightly faster onset of appetite suppression.

Read our full semaglutide vs. tirzepatide comparison for clinical details. Your Telehealth FX clinician will recommend the optimal molecule based on your metabolic profile, insurance situation, and personal response patterns. For more on dosing specifics, see our full titration guide.

Realistic Expectations: What 8 Weeks Actually Looks Like

Let us be honest about outcomes. Based on aggregate clinical data and real-world patient timelines:

  • Conservative responders: 8–10 lbs lost, 1.0–1.5 inches off waist. Noticeable improvement in energy and clothing fit.
  • Average responders: 12–15 lbs lost, 1.5–2.5 inches off waist. Visible body recomposition. Friends and coworkers notice.
  • Strong responders: 15–20 lbs lost, 2.5–3.5 inches off waist. Dramatic visual change, especially in men over 40 with significant visceral fat. See our guide on GLP-1 for men over 50.

Response variability is influenced by starting BMI, insulin resistance status, adherence to the training protocol, and genetic factors affecting GLP-1 receptor sensitivity. The metabolic syndrome population often sees the most dramatic early results due to higher baseline inflammation and insulin levels.

Sleep, Stress, and the Cortisol Factor

No protocol discussion is complete without addressing recovery. Cortisol — the primary stress hormone — directly antagonizes fat loss by promoting visceral fat storage and impairing insulin signaling. A 2022 study in JAMA Internal Medicine (n = 80) found that extending sleep from 6.5 to 8.5 hours per night resulted in 270 fewer calories consumed daily — comparable to the appetite suppression effect of a low-dose GLP-1.

  • Sleep target: 7–9 hours nightly. Non-negotiable during an aggressive fat-loss phase.
  • Caffeine cutoff: No caffeine after 2:00 PM. GLP-1 may affect sleep architecture — do not compound the issue.
  • Stress management: 10 minutes daily of box breathing, meditation, or walking in nature. Chronic stress elevates cortisol, stalls fat loss, and increases GLP-1 side effects.

Common Pitfalls That Derail the 8-Week Window

  1. Under-eating protein. The number one mistake. Appetite suppression makes it easy to eat 1,200 calories of crackers and fruit. Track protein — everything else is secondary.
  2. Skipping resistance training. Cardio alone during a GLP-1 protocol is a recipe for muscle loss. Lift heavy things 3–4 times per week.
  3. Alcohol. Even moderate drinking (2–3 drinks/week) impairs fat oxidation for 24–48 hours post-consumption and amplifies GLP-1 nausea. Read our alcohol guidelines. Consider a full 8-week pause.
  4. Obsessing over the scale. Weight fluctuates 2–5 lbs daily from water, glycogen, and bowel content. Measure waist circumference weekly and take photos biweekly. The mirror is a better judge than the scale during recomposition.
  5. Not adjusting dose with clinical guidance. If you plateau at 0.5 mg, your clinician may recommend advancing to 1.0 mg earlier. If side effects are severe, they may slow titration. This is why provider-guided protocols outperform DIY approaches every time.

What Happens After Week 8?

This protocol is a launchpad, not a finish line. After 8 weeks, you will transition into a maintenance phase with your Telehealth FX clinician. Options include:

  • Continuing at a maintenance dose (often 0.5–1.0 mg) for sustained appetite regulation
  • Advancing to higher doses (1.7 mg or 2.4 mg) if further weight loss is clinically indicated
  • Transitioning to a structured off-ramp with metabolic monitoring to prevent rebound weight gain

The STEP 4 extension trial demonstrated that patients who discontinued semaglutide after 20 weeks regained two-thirds of lost weight within 48 weeks. The Telehealth FX protocol is designed to avoid this cliff — your clinician plans the exit strategy from Day 1.

Frequently Asked Questions

Can I really lose 10–15 lbs in 8 weeks on GLP-1?

Yes, when combined with structured resistance training and high-protein nutrition. Clinical data supports 1.5–2.0 lbs per week of fat loss once therapeutic doses are reached (typically by week 3–4). Individual results vary based on starting weight, metabolic health, and protocol adherence.

Is this safe for someone who has never exercised?

Yes. The training protocol starts with foundational compound movements at moderate intensity. Your Telehealth FX clinician can also connect you with exercise guidance. Start lighter than you think you should — consistency beats intensity in the first two weeks.

What if I have a vacation in the middle of the 8 weeks?

Continue your weekly injection on schedule. Focus on protein intake and walking while traveling. One imperfect week will not ruin six good ones. The appetite suppression effect of GLP-1 makes vacation eating far more controlled than without medication.

How much does this cost?

Telehealth FX programs start at $199/month, which includes the medication, clinician oversight, and ongoing dose management. Many patients use HSA/FSA funds to cover the cost. Read our full cost breakdown.

Eight Weeks. One Decision. A Completely Different Summer.

Clinician-guided GLP-1 protocol with medication shipped to your door. Start today — be ready by August.

Get Started

References

  1. Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 384(11), 989–1002.
  2. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205–216.
  3. Rubino, D., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA, 325(14), 1414–1425.
  4. Sørensen, T. I. A., et al. (2024). Body composition changes during GLP-1 receptor agonist therapy: a systematic review and meta-analysis. The Lancet Diabetes & Endocrinology, 12(3), 198–212.
  5. Tasali, E., et al. (2022). Effect of sleep extension on objectively assessed energy intake among adults with overweight in real-life settings. JAMA Internal Medicine, 182(4), 365–374.
  6. Sorli, C., et al. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1). Diabetes Care, 40(7), 919–926.
  7. Novo Nordisk. (2026). Wegovy (semaglutide) prescribing information: dose titration schedule.